The Role of IL-6 in RA: Expert Perspectives

Por: Sanofi Genzyme
Persistently elevated levels of interleukin-6 (IL-6) in patients with rheumatoid arthritis (RA) are a key driver of articular and systemic manifestations that can significantly impact patients’ quality of life. In this podcast series brought to you by Sanofi Genzyme, we hear from key opinion leaders in the rheumatology space on the broad and important role that IL-6 has in RA.

Visit www.RAandIL6.com for more information.

MAT-US-2106914-v1.0-08/2021 Intended for US Healthcare Professionals. Content jointly developed by KOLs/Sanofi and is not medical advice. KOLs were compensated by Sanofi.
8 episodios disponibles

Latest episodes of the podcast The Role of IL-6 in RA: Expert Perspectives

Elevated IL-6 As a Contributor to Cardiovascular Effects in Patients with RA (with Dr. Leonard Calabrese) 09/08/2021
Bone Resorption: A Manifestation of RA Mediated by Elevated IL-6 (with Dr. Robin Dore) 09/08/2021
The Wide-Reaching Effects of Pain and IL-6 in Rheumatoid Arthritis (with Ms. Amanda Mixon) 09/08/2021
The Role of IL-6 in HPA–Axis-Related Manifestation in RA (with Dr. Sanjay Chabra) 09/08/2021
IL-6: A Key Link Between Innate and Adaptive Immune Responses in RA (with Dr. Gordon Lam) 09/08/2021
A Deeper Dive Into IL-6 Pathway Activation and Downstream Signaling in RA (with Dr. Alvin Wells) 09/08/2021
Dual Signaling: The Driver Behind the Pleiotropic Nature of IL-6 (with Dr. Alan Epstein) 09/08/2021
Beyond the Joints: Systemic Manifestations of IL-6 Elevation in Rheumatoid Arthritis (with Dr. Grace Wright) 09/08/2021
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA